A detailed history of Eagle Wealth Strategies LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Eagle Wealth Strategies LLC holds 4,079 shares of LLY stock, worth $3.25 Million. This represents 2.64% of its overall portfolio holdings.

Number of Shares
4,079
Previous 4,040 0.97%
Holding current value
$3.25 Million
Previous $3.66 Billion 1.2%
% of portfolio
2.64%
Previous 2.96%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$772.14 - $960.02 $30,113 - $37,440
39 Added 0.97%
4,079 $3.61 Billion
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $18,121 - $22,726
25 Added 0.62%
4,040 $3.66 Billion
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $5,922 - $7,922
10 Added 0.25%
4,015 $3.05 Billion
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $2.1 Million - $2.48 Million
4,005 New
4,005 $2.33 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Eagle Wealth Strategies LLC Portfolio

Follow Eagle Wealth Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Wealth Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Wealth Strategies LLC with notifications on news.